Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA(Sipa via AP Images)

September 1, 2020 07:26 AM EDTUpdated 10:44 AM

Covid-19 roundup: AstraZeneca launches 3rd US PhIII vaccine study with a vow to avoid 'cutting corners'

Max Gelman

Senior Editor

John Carroll

Editor & Founder

AstraZeneca has launched the final round of US testing for their closely-watched Oxford vaccine for Covid-19, taking the third spot in line just behind …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca launches 3rd US PhIII vaccine study with a vow to avoid 'cutting corners'

Max Gelman

Senior Editor

John Carroll

Editor & Founder

Sign up to read this article for free.

Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: As­traZeneca launch­es 3rd US PhI­II vac­cine study with a vow to avoid 'cut­ting cor­ner­s'

Senior Editor

Editor & Founder

Sign up to read this article for free.

Covid-19 roundup: AstraZeneca launches 3rd US PhIII vaccine study with a vow to avoid 'cutting corners'